Safety, Tolerability, PK and PD of SAD or MAD of APX-115 in Healthy Male Volunteers
Clinical trial NCT03694041 · COMPLETED
Trial details
- NCT number
- NCT03694041
- Sponsor
- Aptabio Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-28
- Primary completion
- 2019-03-06
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.